Lilly recruits Avidity Biosciences to develop antibody-oligonucleotide conjugates
Tuesday, May 28, 2019 - 20:07
in Biology & Nature
Avidity's technology will help the duo get RNA therapies to immune cells
Avidity's technology will help the duo get RNA therapies to immune cells